Know More About Ovarian Cancer
- Over 230,000 women are diagnosed with ovarian cancer worldwide each year, and about 140,000 women die from the disease.
- 1 in 70 women will develop ovarian cancer in her lifetime.
- Ovarian cancer causes more deaths than any other cancer of the female reproductive system.
DO YOU KNOW SIGNS AND SYMPTOMS?
- There is no early detection test for ovarian cancer. A Pap smear will NOT detect it.
- Ovarian cancer is not a silent killer. In June 2007, a consensus statement outlining specific symptoms was released.
- Know the symptoms! They include bloating, pelvic/abdominal pain, urinary symptoms, difficulty eating, or feeling full quickly.
DO YOU KNOW THE RISKS?
- Recent research indicates that the site of origin for high-grade serous ovarian carcinoma may be the fallopian tube.
- About 5% to 10% of ovarian cancers are caused by the inherited mutation in BRCA1 or BRCA2 genes.
- Women with mutations in the RAD51D gene have a 1 in 11 chance of developing ovarian cancer (Nature Genetics August 2011).
- Lynch syndrome, which is hereditary nonpolyposis colon cancer, is associated with an increased risk of developing ovarian cancer.
- Using estrogen alone as postmenopausal hormone replacement therapy for 10 or more years increases the risk of ovarian cancer (Journal of the American Medical Association July 2002).
- Using oral contraceptives for 5 or more years, pregnancy, or removal of ovaries and fallopian tubes lower a woman's risk of developing ovarian cancer.
DO YOU KNOW ABOUT RELATIVE SURVIVAL?
- Age matters! Women younger than 65 are about twice as likely to survive 5 years (57%) after diagnosis than women 65 years of age and older (27%).
- Women diagnosed with early-stage ovarian cancer have a 5-year survival rate of 93%.
- Only 15% of all ovarian cancer cases are detected at a localized stage; the majority of ovarian cancer is diagnosed at late-stage.
- Women with late-stage ovarian cancer have a 5-year survival rate of about 27%.
DO YOU KNOW YOU HAVE A VOICE IN THE DOD OVARIAN CANCER RESARCH PROGRAM (OCRP)?
- The DoD OCRP is the second-leading federal funding agency for ovarian cancer research in the United States.
- Since the inception of the DoD OCRP, more than 130 ovarian cancer survivors have helped establish the OCRP's priorities and research award mechanisms, and have helped choose the research to be funded.
- The DOD OCRP supports research that:
- Leverages critical research resources;
- Challenges current thinking and approaches;
- Accelerates movement of ideas into clinical applications;
- Supports multidisciplinary and nontraditional collaborations;
- Fosters the next generation of ovarian cancer researchers.